Venture Capital

Altrubio Raises $63M Series A Round To Continue Its Company Transformation

by vcaonline.com posted 5months ago 32 views
REDWOOD CITY, Calif., April 15, 2021-- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company, has announced the completion of a $63 million Series A financing round. The round was led by aMoon with new investors including BVF Partners L.P. (BVF), CAM Capital, and other new and existing investors joining the syndicate. AltruBio’s President & CEO, Dr. Judy Chou stated: “We are honored to have this strong group of investors join us, marking our steady growth and transformation into a truly promising biotech company with great chances of creating value for patients and all our stakeholders.

In this article